Send me a link:

*Text messaging rates may apply.

 Dow Down0.16% Nasdaq Up0.40%

Anika Therapeutics Inc. (ANIK)

-NasdaqGS
48.42 0.45(0.94%) Jul 23, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue 34,010   21,251   17,754   20,828  
Cost of Revenue4,361  6,235  5,378  6,311  
Gross Profit 29,649   15,016   12,377   14,517  
Operating Expenses
Research Development2,288  2,030  1,618  1,829  
Selling General and Administrative3,491  2,400  3,189  3,401  
Non Recurring -  156  (196)(111)
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 23,871   10,431   7,766   9,398  
Income from Continuing Operations
Total Other Income/Expenses Net -   -   -   -  
Earnings Before Interest And Taxes23,871  10,412  7,733  9,362  
Interest Expense -   -   -   -  
Income Before Tax23,871  10,412  7,733  9,362  
Income Tax Expense8,841  3,758  2,776  3,467  
Minority Interest -   -   -   -  
Net Income From Continuing Ops15,030  6,654  4,957  5,895  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 15,030   6,654   4,957   5,895  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 15,030   6,654   4,957   5,895  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.